Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis.
Related Research units
Abstract
The prognostic significance of disseminated tumor cells (DTC) in bone marrow (BM) of breast cancer patients at the time of primary diagnosis has been confirmed by a large pooled analysis. In view of the lack of early indicators for secondary adjuvant treatment, we here evaluated whether the persistence of DTCs after adjuvant therapy increases the risk of subsequent relapse and death.
Bibliographical data
| Original language | English |
|---|---|
| Article number | 9 |
| ISSN | 1078-0432 |
| Publication status | Published - 2011 |
| pubmed | 21415211 |
|---|
